Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11384079 6-5 fused rings as C5a inhibitors

Patent 11384079 was granted and assigned to ChemoCentryx on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ChemoCentryx

Current Assignee

ChemoCentryx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113840790

Patent Inventor Names

Viengkham Malathong0

Yibin Zeng0

Rebecca M. Lui0

Rajinder Singh0

Pingchen Fan0

Penglie Zhang0

Hiroko Tanaka0

Christopher W. Lange0

...

Date of Patent

July 12, 2022

Patent Application Number

167234330

Date Filed

December 20, 2019

Patent Citations

‌

US Patent 10035768 C5aR antagonists

‌

US Patent 10562896 6-5 fused rings as C5a inhibitors

Patent Citations Received

‌

US Patent 11608336 Prodrugs of fused-bicyclic C5aR antagonists

‌

US Patent 11773091 6-5 fused rings as C5a inhibitors

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11384079 6-5 fused rings as C5a inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API